The Role of 5-HT2C Polymorphisms in Behavioral and Psychological Symptoms of Alzheimer Disease

Chapter
First Online:
Part of the The Receptors book series (REC, volume 22)

Abstract

The majority of Alzheimer disease (AD) patients suffer from various psychiatric symptoms, such as depression, psychosis, and anxiety, at some point during the disease process. These symptoms are collectively known as the behavioral and psychological symptoms of dementia (BPSD). Using family studies, a genetic component to BPSD development in AD has been demonstrated. Research has therefore been undertaken to attempt to uncover these genetic susceptibility factors. Genes involved in neurotransmitter systems have been investigated, and the serotonergic system is of particular interest because evidence suggests it plays a role in many aspects of human and animal behavior, including aggression, hallucinations, delusions, depression, anxious behavior, and the regulation of appetite. Therefore the genes encoding components of this system make good candidates for susceptibility factors for BPSD. A variant within the serotonin receptor 5-HT2C gene has been investigated in a few interesting studies, which are reviewed here. Potential associations with psychosis, depression, anxiety, and appetite disturbances have been reported, although the degree to which this variation influences the manifestation of these symptoms may only be small.

Keywords

Alzheimer Disease Visual Hallucination Alzheimer Disease Patient Paired Helical Filament Paired Helical Filament 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

I thank the patients and carers who undertook the clinical trial that gave rise to the work of Pritchard et al. (2008) and the clinicians and nurses who were involved with the study. Funding was from the Birmingham and Solihull NHS, and work was carried out in Dr. Corinne Lendon’s laboratory at the University of Birmingham, Birmingham, UK and at the Queensland Institute of Medical Research, Brisbane, Australia.

References

  1. Assal F, Alarcon M, Soloman E, et al (2004) Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer’s disease. Arch Neurol 61:1249–1253.PubMedCrossRefGoogle Scholar
  2. Barnes N, Sharp T (1999) A review of central 5HT receptors and their functions. Neuropharmacology 38:1083–1152.PubMedCrossRefGoogle Scholar
  3. Burns C, Chu H, Rueter S, et al (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303–308.PubMedCrossRefGoogle Scholar
  4. Castensson A, Aberg K, McCarthy S, et al (2005) Serotonin receptor 2C (HTR2C) and schizophrenia: examination of possible medication and genetic influences on expression levels. Am J Med Genet B Neuropsychiatr Genet 134B:84–89.PubMedCrossRefGoogle Scholar
  5. Chen K, Yang W, Grimsby J, et al (1992) The human 5-HT2 receptor is encoded by a mulitple intron-exon gene. Mol Brain Res 14:20–26.PubMedCrossRefGoogle Scholar
  6. De Luca V, Mueller DJ, de Bartolomeis A, et al (2007) Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol 10:697–704.PubMedGoogle Scholar
  7. Di Matteo V, De Blasi A, Di Giulio C, et al (2001) Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci 22:229–232.PubMedCrossRefGoogle Scholar
  8. Finkel S (2003) Behavioral and psychological symptoms of dementia. Clin Geriatr Med 19:799–824.PubMedCrossRefGoogle Scholar
  9. Fiorella D, Rabin R, Winter J (1995) Role of the 5HT2A and 5HT2C receptors in the stimulus effects of hallucinogenic drugs II: Reassessment of LSD false positives. Psychopharmacology 121:357–363.PubMedCrossRefGoogle Scholar
  10. Gurevich I, Tamir H, Arango V, et al (2002). Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34:349–356PubMedCrossRefGoogle Scholar
  11. Heisler L, Cowley M, Tecott L, et al (2002) Activation of central melanocortin pathways by fenfluramine. Science 297:609–611.PubMedCrossRefGoogle Scholar
  12. Holmes C, Arranz M, Powell J, et al (1998) 5HT2A and 5HT2C receptor polymorphisms and psychopathology in late onset Alzheimer’s disease. Hum Mol Genet 7:1507–1509.CrossRefGoogle Scholar
  13. Holmes C, Arranz M, Collier D, et al (2003) Depression in Alzheimer’s disease: the effect of serotonin receptor gene variation. Am J Med Genet B Neuropsychiatr Genet 119B:40–43.PubMedCrossRefGoogle Scholar
  14. Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:466–476.PubMedGoogle Scholar
  15. Lappalainen J, Zhang L, Dean M, et al (1995) Identification, expression and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2C receptor gene (HTR2C). Genomics 27:274–279PubMedCrossRefGoogle Scholar
  16. Li J, Wang Y, Zhou R, et al (2006) Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects. Neurosci Lett 407:107–111.PubMedCrossRefGoogle Scholar
  17. Lopez-Gimenez JF, Mengod G, Palacios JM, et al (2001) Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA. Synapse 42:12–26.PubMedCrossRefGoogle Scholar
  18. Lopez-Gimenez JF, Tecott LH, Palacios JM, et al (2002) Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J Neurosci Res 67:69–85.PubMedCrossRefGoogle Scholar
  19. Lyketsos CG, Tune L, Pearlson G, et al (1996) Major depression in Alzheimer’s disease. An interaction between gender and family history. Psychosomatics 37:380–384.PubMedCrossRefGoogle Scholar
  20. Mengod G, Vilaro MT, Raurich A, et al (1996) 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors. Histochem J 28:747–758.PubMedCrossRefGoogle Scholar
  21. Miller DD, Ellingrod VL, Holman TL, et al (2005) Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet 133B:97–100.PubMedCrossRefGoogle Scholar
  22. Pearlson G, Ross C, Lohr W, et al (1990) Association between family history of affective disorder and the depressive syndrome of Alzheimer’s disease. Am J Psychiatry 147:452–456.PubMedGoogle Scholar
  23. Pooley EC, Fairburn CG, Cooper Z, et al (2004) A 5-HT2C receptor promoter polymorphism (HTR2C–759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet B Neuropsychiatr Genet 126B: 124–127.PubMedCrossRefGoogle Scholar
  24. Porteous D (2008) Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new. Curr Opin Genet Dev 18:229–234.PubMedCrossRefGoogle Scholar
  25. Praschak-Rieder N, Willeit M, Zill P, et al (2005) Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study. J Psychiatr Res 39:561–567.PubMedCrossRefGoogle Scholar
  26. Pritchard AL, Harris J, Pritchard CW, et al (2008) Role of 5HT 2A and 5HT 2C polymorphisms in behavioral and psychological symptoms of Alzheimer’s disease. Neurobiol Aging 29:341–347.PubMedCrossRefGoogle Scholar
  27. Rang H, Dale M, Ritter J, et al (2003) Pharmacology. 5th Edition. London: Churchill Livingstone, pp. 244–253.Google Scholar
  28. Reynolds GP, Zhang ZJ, Zhang XB (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359:2086–2087.PubMedCrossRefGoogle Scholar
  29. Ryu S, Cho EY, Park T, et al (2007) -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry 31:673–677.PubMedCrossRefGoogle Scholar
  30. Saltzman A, Morse B, Whitman M, et al (1991) Cloning of the human serotonin 5HT2 and 5HT1C receptor subtypes. Biochem Biophys Res Commun 18:1469–1478.CrossRefGoogle Scholar
  31. Steele C, Rovner B, Chase GA, et al (1990) Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry 147:1049–1051.PubMedGoogle Scholar
  32. Strauss ME, Ogrocki PK (1996) Confirmation of an association between family history of affective disorder and the depressive syndrome in Alzheimer’s disease. Am J Psychiatry 153:1340–1342.PubMedGoogle Scholar
  33. Sweet RA, Nimganokar V, Devlin B, et al (2002) Increased familial risk of the psychotic phenotype of Alzheimer’s disease. Neurology 58:907–911.PubMedCrossRefGoogle Scholar
  34. Tecott L, Sun L, Akana S, et al (1995) Eating disorder and epilepsy in mice lacking 5HT2C serotonin receptors. Nature 374:542–546.PubMedCrossRefGoogle Scholar
  35. Tunstall N, Owen M, Williams J, et al (2000) Familial influence on variation in age of onset and behavioral phenotype in Alzheimer’s disease. Br J Psychiatry 176:156–159.PubMedCrossRefGoogle Scholar
  36. Ujike H, Nomura A, Morita Y, et al (2008) Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry 69(9):1416–1422.PubMedCrossRefGoogle Scholar
  37. Xie E, Zhu L, Zhao L, et al (1996) The human serotonin 5-HT2C receptor: Complete cDNA, genomic structure and alternatively spliced variant. Genomics 35:551–561.PubMedCrossRefGoogle Scholar
  38. Zhang Z, Zhang X, Yao Z, et al (2002) (Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene.) Zhonghua Yi Xue Za Zhi 82:1097–1101.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Molecular Psychiatry Group, G Floor, CBCRC BuildingQueensland Institute of Medical ResearchBrisbaneAustralia

Personalised recommendations